U.S. Tech Hardware Stock News

In April 2026, Nicolet Bankshares, Inc. reported first-quarter results showing net interest income of US$109.56 million but lower net income of US$15.2 million, alongside higher net loan charge-offs of US$833,000 compared with a year earlier. The company also continued returning capital to shareholders through its long-running buyback program and announced a higher quarterly dividend of US$0.36 per share payable on June 15, 2026. We’ll now examine how the combination of weaker earnings and a...

Marriott Vacations Worldwide (VAC) heads into its next earnings report on May 5, 2026, with expectations shaped by a pattern of earnings beats, a positive Earnings ESP of 2.88%, and continued analyst support. See our latest analysis for Marriott Vacations Worldwide. The recent 33.78% 3 month share price return and 7.95% 1 month share price return to US$72.75 suggest momentum has improved in the short term, even though the 3 year total shareholder return remains a 37.08% loss. If earnings...

Compass (COMP) continues to attract attention after a mixed share price pattern, with a small gain over the past month contrasting with weaker returns over the past 3 months and year to date. See our latest analysis for Compass. While the recent 7 day share price return of 5.86% decline and 1 day move of 2.38% decline point to fading short term momentum, Compass still shows a very large 3 year total shareholder return of 196.79% despite a 7.04% decline over 1 year. If you are weighing Compass...

If you are wondering whether Sonos shares still offer value at around US$14.84, it helps to first line up what the recent price action and current fundamentals are really telling you. Over the last week Sonos returned 0.6%, over the past month it returned 9.3%, yet year to date the stock is down 15.2% after a 56.9% return over the past year and longer term returns over 3 and 5 years of 31.3% and 60.5% declines. These mixed returns frame recent news flow that has kept Sonos on investors'...

In the past week, Terex Corporation reported first-quarter 2026 results showing sales of US$1,734 million versus US$1,229 million a year earlier, but a net loss of US$89 million driven largely by merger-related accounting and amortization charges tied to the REV Group acquisition. Management reaffirmed full-year 2026 guidance for net sales of US$7.50 billion to US$8.10 billion and highlighted progress on integrating REV Group into a new Specialty Vehicles segment, with targeted cost and...

Penske Automotive Group reported past first-quarter 2026 results with sales of US$7,657.8 million, net income of US$234.5 million, and basic earnings per share of US$3.56, slightly lower than a year earlier but ahead of analyst expectations. The quarter highlighted record service and parts revenue and new Lexus dealership acquisitions expected to add US$450 million in annualized sales, helping offset softer new-vehicle and commercial truck demand. Next, we’ll examine how this record service...

Pebblebrook Hotel Trust reported first-quarter 2026 results showing revenue of US$345.66 million and a net loss of US$19.27 million, both improved from a year earlier. The company paired these results with a wide full-year 2026 outlook ranging from a US$6.00 million net loss to a US$6.00 million net profit, underlining both progress and uncertainty. Next, we’ll examine how the improved first-quarter loss and raised full-year guidance shape Pebblebrook’s existing investment narrative. We've...

WisdomTree (WT) is in focus after reporting first quarter 2026 results that included record assets under management, higher quarterly revenue, a completed Atlantic House acquisition, and fresh progress in tokenized products and partnerships. See our latest analysis for WisdomTree. At a share price of $16.62, WisdomTree has seen strong momentum build recently, with a 30 day share price return of 15.02% and a year to date share price return of 32.85%. The 1 year total shareholder return of...

Recently, CG Oncology, Inc. was upgraded to a Zacks Rank #2 (Buy) following an upward trend in its earnings estimates, reflecting increased optimism about its earnings outlook. This shift in analyst sentiment highlights how changes in projected earnings can quickly reshape perceptions of a company’s underlying business strength. We’ll now examine how this analyst upgrade, driven by rising earnings estimates, influences CG Oncology’s broader investment narrative for investors. Outshine the...

Mosaic (MOS) is back in focus after outlining streamlined 2030 sustainability targets that center on workplace safety, water management, decarbonization planning, soil health across more than 100 million acres, and responsible reuse of tailings. See our latest analysis for Mosaic. The sustainability update lands at a time when Mosaic’s share price has come under pressure, with a 30 day share price return of 11.54% and a 1 year total shareholder return decline of 21.79%, suggesting sentiment...

Phillips Edison (PECO) raised its full year 2026 net income guidance to a range of $0.79 to $0.81 per share, up from $0.74 to $0.77, following first quarter earnings. See our latest analysis for Phillips Edison. That guidance bump comes after a solid run in the share price, with a year to date share price return of 13.04% and a 1 year total shareholder return of 16.24%. The 5 year total shareholder return of 153.15% points to sustained momentum rather than a short term spike. If earnings...

In recent days, National HealthCare Corporation has drawn scrutiny after bearish commentary underscored risks from its 2026 rent reset, potential EBITDA compression, and operational headwinds including staffing pressures, quality concerns, and reimbursement challenges. This critique, set against governance shifts and activist pressure at key landlord National Health Investors, raises fresh questions about the resilience of NHC’s traditional skilled-nursing–centric model. Against this...

Recent stock performance snapshot Everus Construction Group (ECG) has drawn attention after a series of strong returns, including a move of about 10% over the past week and roughly 20% over the past month. See our latest analysis for Everus Construction Group. Those recent short term gains sit on top of a much stronger run, with a 64.5% 90 day share price return and a 1 year total shareholder return of about 230%, suggesting momentum has been building as investors reassess growth prospects...

Alignment Healthcare (ALHC) just reported a profitable first quarter, with revenue of US$1,235.2 million, net income of US$11.42 million, and earnings per share ahead of expectations, while also raising its full-year revenue guidance. See our latest analysis for Alignment Healthcare. Despite the strong first quarter profit and higher full year guidance, Alignment Healthcare’s recent share price has been volatile, with a 1 day share price return of a 10.12% decline but a 1 year total...

Bloom Energy (BE) has delivered strong recent share price swings, with returns of 25.7% over the past week and 114.2% over the past month. This has put its valuation and business profile back in focus for investors. See our latest analysis for Bloom Energy. Those sharp recent gains sit on top of a 194.38% year to date share price return and a very large 1 year total shareholder return, pointing to strong momentum and a meaningful shift in how the market is pricing Bloom Energy’s growth...

Why Copart is on investors’ radar today Copart (CPRT) is drawing attention after a period in which the stock shows a 16.15% decline over the past 3 months and a 45.66% decline over the past year. This recent performance is prompting closer scrutiny of its underlying business. See our latest analysis for Copart. Despite a modest 0.6% 7 day share price return at around US$33.27, Copart’s recent 3 month share price return of negative 16.15% and 1 year total shareholder return of negative 45.66%...

Ocular Therapeutix (OCUL) is back in focus after enrolling the first patient in its SOL-X long-term extension trial for AXPAXLI in wet age-related macular degeneration, alongside ongoing FDA discussions and New Drug Application preparations. See our latest analysis for Ocular Therapeutix. Despite the steady flow of clinical and regulatory updates around AXPAXLI, Ocular Therapeutix’s share price has been volatile, with an 11.07% 1 month share price return at a latest share price of US$9.43, a...

D.R. Horton (DHI) is back in focus after its latest quarterly update, which combined softer year over year earnings, a trimmed yet still higher full year revenue outlook, and ongoing pressure from housing affordability. See our latest analysis for D.R. Horton. The share price has been under pressure in the short term, with a 1 day share price return of a 2.52% decline and a 7 day share price return of a 6.20% decline, even though the 1 year total shareholder return is 18.82%. This suggests...

Recent performance snapshot Fidelis Insurance Holdings (NYSE:FIHL) has drawn attention after a recent stretch of positive share performance, with the stock up over the past week, month, and past 3 months, and closing at US$21.21. See our latest analysis for Fidelis Insurance Holdings. That recent momentum fits into a stronger run for investors, with a 1 year total shareholder return of 31.39% alongside a 90 day share price return of 10.35%, suggesting sentiment has been improving. If this...

Oscar Health (OSCR) is drawing fresh attention after launching its Lucie Health Marketplace, an all-in-one storefront for individual and employer health benefits, as investors also look ahead to the company’s upcoming earnings report. See our latest analysis for Oscar Health. At a share price of $18.49, Oscar Health has seen strong recent momentum, with a 30 day share price return of 55.12% and a 1 year total shareholder return of 40.08%. This builds on a very large 3 year total shareholder...

In April 2026, Matador Resources Company promoted Christopher P. Calvert to Executive Vice President and Chief Financial Officer and Glenn W. Stetson to Executive Vice President and Chief Operating Officer, while its board also approved a quarterly cash dividend of US$0.375 per share payable on June 5, 2026. These leadership changes and continued cash returns to shareholders come as Matador faces softer earnings expectations and heightened sensitivity to global oil price movements driven by...

BofA Securities recently began covering Global Business Travel Group, Inc. with a neutral rating, while Citi reiterated a positive stance, both focusing on the company’s business model and technology positioning against newer competitors. Together, these differing analyst views highlight a tension between concerns over legacy booking infrastructure and confidence in Global Business Travel Group’s ongoing execution and service capabilities. We’ll now examine how BofA’s concerns about legacy...

Constellation Brands (STZ) is drawing attention after launching Modelo Chelada Suprema nationwide. It is the first high-ABV entry in the Modelo lineup and is directly targeting demand for stronger, flavor-forward ready-to-drink options among younger drinkers. See our latest analysis for Constellation Brands. Despite the buzz around Modelo Chelada Suprema, Constellation Brands' recent share price performance has been mixed, with a 1 month share price return of 1.07% and a year to date share...

In the past week, Wayfair reported first-quarter 2026 results with net revenue of US$2.93 billion, up from US$2.73 billion a year earlier, while narrowing its net loss to US$105 million and improving both adjusted profitability and key customer metrics. Management highlighted that this was Wayfair’s best first-quarter adjusted EBITDA margin in five years, with active customers returning to growth and the company gaining share in a weak home furnishings market despite ongoing losses. We’ll...